Pfizer tops earnings estimates as Covid product sales beat expectations

Pfizer reported fourth-quarter earnings and revenue that beat expectations, driven by stronger-than-expected Covid product sales and cost-cutting efforts. The company posted adjusted earnings per share of 63 cents, surpassing the expected 46 cents, with revenue reaching $17.76 billion, higher than the $17.36 billion forecasted. Shares of Pfizer rose 2% in premarket trading. The company has been cutting costs to recover from the decline of its … Continue reading Pfizer tops earnings estimates as Covid product sales beat expectations

PepsiCo earnings beat estimates, but demand for drinks and snacks drops

PepsiCo reported mixed quarterly results as North American demand for its snacks and drinks declined for the fifth straight quarter. Shares fell more than 2% in premarket trading. The company reported adjusted earnings per share of $1.96, slightly beating the $1.94 expected. Revenue came in at $27.78 billion, just below the expected $27.89 billion. Net income rose to $1.52 billion, or $1.11 per share, from … Continue reading PepsiCo earnings beat estimates, but demand for drinks and snacks drops

US adds 254K jobs in September

September’s strong payroll growth has lifted the U.S. economy out of recession fears, providing the Federal Reserve with a favorable outlook for achieving a soft landing. The addition of 254,000 jobs surpassed expectations and marked a significant rebound from previous trends of slowing job growth, easing inflation concerns and allowing for declining interest rates. This positive momentum has boosted confidence in sustained economic strength, with … Continue reading US adds 254K jobs in September